Lisa Walters-Hoffert - 24 Jan 2023 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Reporting relationship: Chief Financial Officer
Issuer ticker: DARE
Reported as of: 24 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Jan 2023, 15:06:19 UTC
Prior SEC filing: 02 May 2022
Next SEC filing: 08 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Lisa Walters-Hoffert

Key filing fact

Lisa Walters-Hoffert filed Form 4 for Dare Bioscience, Inc. (DARE) on 26 Jan 2023.

Key facts

This page summarizes Lisa Walters-Hoffert's Form 4 filing for Dare Bioscience, Inc. (DARE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 Jan 2023, 15:06.

Change

Previous filing in this sequence was filed on 02 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DARE transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +290,000
Change %
Price: $0.000000
Shares after: 290,000
Date: 24 Jan 2023
Ownership: Direct
Underlying class: Common stock
Underlying amount: 290,000
Exercise price: $1.16
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.